诺和诺德推出Wegovy口服药,医保患者月费25美元,自费149美元。
Novo Nordisk launches Wegovy pill at $25 per month for insured patients, $149 cash
生物技术与制药领域的最新动态
Novo Nordisk launches Wegovy pill at $25 per month for insured patients, $149 cash
10 clinical trials to watch in the first half of 2026
Strategic diagnostic testing partnerships are accelerating clinical research
Cynosure Group LLC Sells 5,293 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Teverelix: A New Direction in Prostate Cancer and Urologic Health
Insilico, fresh off its Hong Kong IPO, pens potential $888M cancer R&D pact with Servier
Thermo Fisher (TMO) stock closes higher into 2026 — what to watch before Jan. 29 earnings - ts2.tech
Population analyses reveal heterogenous encoding in the medial prefrontal cortex during naturalistic foraging
Female moths incorporate plant acoustic emissions into their oviposition decision-making process
CCDC32 stabilizes clathrin-coated pits and drives their invagination
Identifying new targets in the fight against opioids
Thermo Fisher stock closes higher near 52-week high as January data, earnings loom - ts2.tech
Who Owns Agilent Technologies? Top Shareholders and Recent Insider Trades - TIKR.com
Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT) - simplywall.st
Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT) - simplywall.st
Penobscot Investment Management Company Inc. Sells 8,029 Shares of Agilent Technologies, Inc. $A - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Buys Shares of 5,847 Waters Corporation $WAT - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by GAM Holding AG - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom - ts2.tech